These data indicated that similar mechanisms by which cancer cells lacking class I MHC molecules express CEACAM1 ligands to suppress the killing activity of NK cells are also adopted by colorectal tumor cells and might be common in all kinds of cancers. This evidence concerns the gene CEACAM1 and colorectal neoplasm.